PLSE (STOCKS)
Pulse Biosciences, Inc Common Stock (DE)
$44.920000
+1.600000 (+3.69%)
Prev close: $43.320000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Paul A. LaViolette
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,681.76M
- Employees
- 75
- P/E (TTM)
- -38.25
- P/B (TTM)
- 30.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.19M |
| Benefits Costs and Expenses | -$65.51M |
| Cost Of Revenue | $1.18M |
| Costs And Expenses | $84.23M |
| Gross Profit | $3.00K |
| Nonoperating Income/Loss | $2.99M |
| Operating Expenses | $83.05M |
| Selling, General, and Administrative Expenses | $31.16M |
| Research and Development | $51.89M |
| Operating Income/Loss | -$83.04M |
| Income/Loss From Continuing Operations After Tax | $65.53M |
| Income/Loss From Continuing Operations Before Tax | $66.70M |
| Net Income/Loss | -$80.06M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$80.06M |
| Net Income/Loss Available To Common Stockholders, Basic | -$80.06M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.18 |
| Basic Average Shares | 136,117,962 |
| Assets | $115.56M |
| Current Assets | $105.70M |
| Inventory | $236.00K |
| Other Current Assets | $105.46M |
| Noncurrent Assets | $9.86M |
| Fixed Assets | $1.06M |
| Other Non-current Assets | $8.80M |
| Liabilities | $16.06M |
| Current Liabilities | $10.98M |
| Accounts Payable | $2.83M |
| Wages | $3.69M |
| Other Current Liabilities | $4.45M |
| Noncurrent Liabilities | $5.09M |
| Equity | $99.50M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $99.50M |
| Liabilities And Equity | $115.56M |
| Net Cash Flow From Operating Activities | -$61.10M |
| Net Cash Flow From Operating Activities, Continuing | -$61.10M |
| Net Cash Flow From Investing Activities | -$290.00K |
| Net Cash Flow From Investing Activities, Continuing | -$290.00K |
| Net Cash Flow From Financing Activities | $56.66M |
| Net Cash Flow From Financing Activities, Continuing | $56.66M |
| Net Cash Flow | -$4.73M |
| Net Cash Flow, Continuing | -$4.73M |
| Comprehensive Income/Loss | -$80.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$80.06M |
| Other Comprehensive Income/Loss | -$80.06M |